As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Author(s)

-
Gregory A. Poland, MD
Mary Lowell Leary Professor of Medicine, Infectious Diseases, Molecular Pharmacology, and Experimental Therapeutics, Mayo
Clinic College of Medicine, Rochester, Minnesota; Director, Mayo Vaccine Research Group, Rochester, Minnesota; Director, Translational
Immunovirology and Biodefense Program, Mayo Clinic, Rochester, Minnesota
Disclosures
Disclosure: Gregory A. Poland, MD, MACP, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Novavax, Inc.; Merck & Co., Inc.; Avianax, LLC; GlaxoSmithKline; Novartis Vaccines;
Emergent BioSolutions; Theraclone Sciences; MedImmune, Inc.; Liquidia Technologies, Inc.
Received grants for clinical research from: Novavax, Inc.; Merck & Co., Inc.; Wyeth Pharmaceuticals Inc.